investigational site number 01Rhead — Milwaukee, Wisconsin

investigational site number 01Rhead is a clinical research site located in Milwaukee, Wisconsin, United States 53201-1997.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

investigational site number 01Rhead has participated in 1 clinical trials.

Therapeutic areas: Fabry Disease, Alpha Galactosidase A Deficiency.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for investigational site number 01Rhead?

investigational site number 01Rhead has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has investigational site number 01Rhead conducted?

investigational site number 01Rhead has 1 clinical trials on record. Their work covers Fabry Disease, Alpha Galactosidase A Deficiency.

Is investigational site number 01Rhead accredited by Crixeo Health?

investigational site number 01Rhead has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about investigational site number 01Rhead?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.